Cresco Labs Inc. (CL.CN)
- Previous Close
1.0100 - Open
1.0400 - Bid 0.9200 x --
- Ask 1.0000 x --
- Day's Range
0.9400 - 1.0600 - 52 Week Range
0.7500 - 2.9300 - Volume
239,260 - Avg. Volume
157,708 - Market Cap (intraday)
334.655M - Beta (5Y Monthly) 1.82
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3100 - Earnings Date May 20, 2025 - May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.52
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's Edibles brand, as well as licenses the Kiva brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
www.crescolabs.com2,900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CL.CN
View MorePerformance Overview: CL.CN
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CL.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CL.CN
View MoreValuation Measures
Market Cap
334.65M
Enterprise Value
1.04B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.33
Price/Book (mrq)
0.50
Enterprise Value/Revenue
1.02
Enterprise Value/EBITDA
6.49
Financial Highlights
Profitability and Income Statement
Profit Margin
-10.40%
Return on Assets (ttm)
5.16%
Return on Equity (ttm)
-14.82%
Revenue (ttm)
715.76M
Net Income Avi to Common (ttm)
-74.44M
Diluted EPS (ttm)
-0.3100
Balance Sheet and Cash Flow
Total Cash (mrq)
137.56M
Total Debt/Equity (mrq)
164.78%
Levered Free Cash Flow (ttm)
4.59M